Varian earnings jump
Net earnings at Varian Medical Systems grew 41% to $32 million during third quarter 2003 on a 23% rise in sales over the year-earlier period-and the future looks even brighter. Net orders in the quarter rose 14%, and the backlog jumped 18% to $789
Net earnings at Varian Medical Systems grew 41% to $32 million during third quarter 2003 on a 23% rise in sales over the year-earlier period-and the future looks even brighter. Net orders in the quarter rose 14%, and the backlog jumped 18% to $789 million. Company executives report sales growth in double digits across all business segments with brightening prospects in emerging product lines, including brachytherapy systems, as well as nonmedical security and inspection equipment.
This is the fourth consecutive year net earnings have grown by more than 40%, according to the company. Oncology Systems sales of Clinac accelerators as well as accessories, software, and services for radiation therapy totaled $218 million for the quarter, up 25% from the prior-year period. Orders for intensity-modulated and image-guided radiotherapy products also rose. Third quarter net orders in the Oncology Systems business totaled $242 million, up 18% with especially strong performance in Europe. X-ray products sales, including tubes and amorphous silicon flat-panel digital imagers, accounted for $37 million, up 11% from the year-ago quarter. The company predicts that sales for fiscal year 2003 will overshadow fiscal 2002 totals by about 18%.
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
Study: Contrast-Enhanced Mammography Changes Surgical Plan in 22.5 Percent of Breast Cancer Cases
December 7th 2023Contrast-enhanced mammography detected additional lesions in 43 percent of patients and led to additional biopsies in 18.2 percent of patients, over half of whom had malignant lesions, according to a study of over 500 women presented at the recent Radiological Society of North America (RSNA) conference.
